Ryan E Hartung

Title: Ryan E Hartung: Innovator in Pharmaceutical Chemistry

Introduction

Ryan E Hartung is a prominent inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work focuses on developing novel compounds that have therapeutic applications, particularly in treating central nervous system disorders.

Latest Patents

One of Hartung's latest patents is titled "Substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof." This patent discloses a series of substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives that act as modulators of H3 receptors. These compounds are particularly useful as pharmaceutical agents in the treatment and prevention of various diseases associated with the central nervous system.

Another significant patent is "Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof." This invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, which are modulators of metabotropic glutamate receptors, specifically the mGluR2 receptor. These compounds are valuable in treating a range of central nervous system disorders, including neurodegenerative conditions, psychoses, and anxiety.

Career Highlights

Ryan E Hartung is currently employed at Sanofi, a global biopharmaceutical company. His work at Sanofi has allowed him to focus on innovative drug development, contributing to advancements in pharmaceutical science. His expertise in the field has positioned him as a key player in the development of new therapeutic agents.

Collaborations

Throughout his career, Hartung has collaborated with notable colleagues, including Zhongli Gao and Daniel Hall. These collaborations have fostered a productive environment for innovation and have led to the successful development of several patented compounds.

Conclusion

Ryan E Hartung is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of central nervous system disorders. His contributions through innovative patents and collaborations continue to impact the field positively.